Rebel Curd is a speaker at Global Transfer Pricing: Key Strategies and New Opportunities for Pharma/Biotech Companies. Rebel moderated a panel entitled, “Global Audit Planning and Defense”.
For more information on this event, click here.
Highlights from 2025 and looking forward to 2026
In the United States, 2025 brought major activity in high profile transfer pricing disputes and reaffirmed how closely transfer pricing, tariffs, and customs...